Primotec Group Ltd
Primotec Group Ltd has a market price of 1,399 ILS per share and a market capitalization of 20.36 billion ILS, with a price-to-earnings ratio of 893.08 and a price-to-book ratio of 116.25. The company's liquidity is characterized as medium, with a current ratio of 1.7 and cash and equivalents of 2.98 million ILS, which is significantly lower than its long-term debt of 35.73 million ILS. The company's return on equity is 13.02%, and its return on assets is 9.04%, indicating a relatively strong profitability compared to the industry median for Commodity Chemicals. The company's profitability is further reflected in its gross profit of 105.61 million ILS and operating income of 36.90 million ILS, with a net income of 22.80 million ILS. These figures suggest that the company is generating substantial profits from its operations, which is a positive sign for its financial health. The company's debt-to-equity ratio of 0.2 indicates a conservative capital structure, with total liabilities of 76.91 million ILS and total equity of 175.13 million ILS. Primotec Group Ltd's revenue is derived from two main areas: the institutional sector, which markets products directly to the institutional market, and the retail sector, which markets products through marketers and retailers to the final consumer. The company's revenue concentration is not disclosed, but its operations span a diverse range of products and services, including cleaning products, paper products, disposable products, and medical equipment. This diversification may help mitigate risks associated with any single market or product line. The company's growth trajectory is not explicitly stated, but its operating cash flow of 42.03 million ILS and free cash flow of -3.14 million ILS suggest that it is generating positive cash flow from operations, although it is not sufficient to cover its capital expenditures of 10.58 million ILS. The company's capital expenditures are primarily driven by its need to maintain and expand its production capabilities, which is a common practice in the Commodity Chemicals industry. The company's risk assessment indicates a medium liquidity risk and a low dilution risk, with key flags including negative net cash after subtracting total debt. The company's liquidity position is further supported by its operating cash flow, which is significantly higher than its free cash flow, indicating that the company is able to generate sufficient cash to meet its operational needs. The company's dilution risk is low, with no significant dilution sources identified in the risk assessment. Recent events and filings for Primotec Group Ltd are not explicitly detailed, but the company's financial performance and risk profile suggest that it is a stable and profitable entity within the Commodity Chemicals industry. The company's ability to generate positive operating cash flow and maintain a conservative capital structure supports its financial stability and resilience to market fluctuations.
Business. Primotec Group Ltd is an Israel-based privately held company that produces, imports, and sells a wide range of cleaning products, paper products, disposable products, and medical equipment, while also generating electricity for utility companies.
Classification. Primotec Group Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.
- Primotec Group Ltd has a high price-to-earnings ratio of 893.08, indicating that the market is valuing the company at a premium relative to its earnings.
- The company's return on equity of 13.02% and return on assets of 9.04% suggest strong profitability and efficient use of capital.
- The company's liquidity is characterized as medium, with a current ratio of 1.7 and cash and equivalents of 2.98 million ILS, which is significantly lower than its long-term debt of 35.73 million ILS.
- The company's operations are diversified across two main areas: the institutional sector and the retail sector, which may help mitigate risks associated with any single market or product line.
- # RATIONALES
- **margin_outlook_rationale**: The company's gross profit margin is expected to remain stable due to its diversified product portfolio and strong market position in the institutional and retail sectors.
- **rd_outlook_rationale**: Research and development expenditures are not explicitly detailed, but the company's focus on a wide range of products suggests ongoing innovation in its product offerings.
- **capex_outlook_rationale**: Capital expenditures are expected to remain moderate as the company continues to maintain and expand its production capabilities to meet market demand.
- Net cash is negative after subtracting total debt.